These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 31106335)
1. New drugs: big changes in conservative heart failure therapy? Berliner D; Bauersachs J Eur J Cardiothorac Surg; 2019 Jun; 55(Suppl 1):i3-i10. PubMed ID: 31106335 [TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin-aldosterone system inhibitors in heart failure. Shearer F; Lang CC; Struthers AD Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393 [TBL] [Abstract][Full Text] [Related]
3. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments. Naegele M; Flammer AJ; Enseleit F; Ruschitzka F Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014 [TBL] [Abstract][Full Text] [Related]
4. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry. Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ; JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482 [TBL] [Abstract][Full Text] [Related]
5. Obesity-Related Heart Failure With a Preserved Ejection Fraction: The Mechanistic Rationale for Combining Inhibitors of Aldosterone, Neprilysin, and Sodium-Glucose Cotransporter-2. Packer M; Kitzman DW JACC Heart Fail; 2018 Aug; 6(8):633-639. PubMed ID: 29525327 [TBL] [Abstract][Full Text] [Related]
6. An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF). Raj L; Adhyaru B Postgrad Med J; 2016 Dec; 92(1094):726-734. PubMed ID: 27708003 [TBL] [Abstract][Full Text] [Related]
8. Management of Heart Failure Patient with CKD. Banerjee D; Rosano G; Herzog CA Clin J Am Soc Nephrol; 2021 Jul; 16(7):1131-1139. PubMed ID: 33495289 [TBL] [Abstract][Full Text] [Related]
9. Combination Therapy of Renin Angiotensin System Inhibitors and β-Blockers in Patients with Heart Failure. Nochioka K; Sakata Y; Shimokawa H Adv Exp Med Biol; 2018; 1067():17-30. PubMed ID: 29542073 [TBL] [Abstract][Full Text] [Related]
10. Benefits and Risks of Continuing Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists, and Mineralocorticoid Receptor Antagonists during Hospitalizations for Acute Heart Failure. Oliveros E; Oni ET; Shahzad A; Kluger AY; Lo KB; Rangaswami J; McCullough PA Cardiorenal Med; 2020; 10(2):69-84. PubMed ID: 32062648 [TBL] [Abstract][Full Text] [Related]
11. How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?: A Redefinition of Evidence-Based Medicine. McMurray JJV; Packer M Circulation; 2021 Mar; 143(9):875-877. PubMed ID: 33378214 [No Abstract] [Full Text] [Related]
12. The renin-angiotensin-aldosterone system in heart failure for the non-specialist: the past, the present and the future. Orsborne C; Chaggar PS; Shaw SM; Williams SG Postgrad Med J; 2017 Jan; 93(1095):29-37. PubMed ID: 27671772 [TBL] [Abstract][Full Text] [Related]
13. Hyperkalemia in heart failure: Foe or friend? Rakisheva A; Marketou M; Klimenko A; Troyanova-Shchutskaia T; Vardas P Clin Cardiol; 2020 Jul; 43(7):666-675. PubMed ID: 32445223 [TBL] [Abstract][Full Text] [Related]
14. Current drug therapy for heart failure with reduced ejection fraction. Berliner D; Hallbaum M; Bauersachs J Herz; 2018 Aug; 43(5):383-391. PubMed ID: 29777284 [TBL] [Abstract][Full Text] [Related]
16. Impact of Hyperkalemia and Worsening Renal Function on the Use of Renin Angiotensin Aldosterone System Inhibitors in Chronic Heart Failure With Reduced Ejection Fraction. Pitt B; Rossignol P Clin Pharmacol Ther; 2017 Sep; 102(3):389-391. PubMed ID: 28707341 [TBL] [Abstract][Full Text] [Related]
17. Personalizing heart failure management in chronic kidney disease patients. Banerjee D; Wang AY Nephrol Dial Transplant; 2022 Oct; 37(11):2055-2062. PubMed ID: 33591313 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis. Tseng AS; Kunze KL; Lee JZ; Amin M; Neville MR; Almader-Douglas D; Killu AM; Madhavan M; Cha YM; Asirvatham SJ; Friedman PA; Gersh BJ; Mulpuru SK Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e006951. PubMed ID: 31159582 [TBL] [Abstract][Full Text] [Related]
19. Current challenges in the management of heart failure. Komajda M Circ J; 2015; 79(5):948-53. PubMed ID: 25877621 [TBL] [Abstract][Full Text] [Related]
20. Novelties in Therapy of Chronic Heart Failure. Doimo S; Pavan D Heart Fail Clin; 2021 Apr; 17(2):255-262. PubMed ID: 33673949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]